Khairunisa Suleiman

Recent Contributions

Reply to WHO recommendation of injectable-free regimens for the treatment of RR/MDR-TB*

Aug. 20, 2018
Countries will have to conform to providing wide access to bedaquiline and particularly safer treatment options for patients. There is no excuse now that bedaquiline is a core drug in the long regimen. We have our work cut out for us to ensure wide access to the long regimen.

TB CAB response to rapid communications on new WHO DR-TB regimen recommendations

Aug. 17, 2018
Please find below TB CAB's response to the rapid communication on the new DR-TB regimen recommendation:

Reply to GeneXpert Omni - Hype or Hope? Concerns from the global diagnositc community

Feb. 7, 2018
Thanks Kathleen for posting this factsheet on Omni. What is remarkably worrying with Omni is that the marketing has preceded it's performance. Such that we don't know about it's performance, it is not endorsed by WHO, yet people globally and on the ground are actively advocating for it's use. Responsible ...

Reply to Diagnostic training programs in Kenya?

Feb. 7, 2018
Hi Melissa, Thanks to Erica Lessem for bringing your question to my attention. I asked a friend and she said the following: "We do have trainings at GE. Mostly for imaging equipment: MRI/CT/X-ray / ultrasound and monitoring devices - monitors, ECG, Anaesthesia etc. we have a training centre in Karen." ...

TB LAM to be introduced in Kenya partly due to TB Activists

Nov. 23, 2017
Let history note that Kenya is set to be one of the few countries to implement TB LAM. TB Activists urged the Government to introduce TB LAM a few months ago, which partly led to the Government's decision to implement the test and promptly allocate USD 300 000 for test ...

Recent Recommendations

"TB LAM to be introduced in Kenya partly due to TB Activists"

Global Health Diagnostics